201 related articles for article (PubMed ID: 15339051)
1. New insights into syndecan-2 expression and tumourigenic activity in colon carcinoma cells.
Han I; Park H; Oh ES
J Mol Histol; 2004 Mar; 35(3):319-26. PubMed ID: 15339051
[TBL] [Abstract][Full Text] [Related]
2. Syndecan-2 mediates adhesion and proliferation of colon carcinoma cells.
Park H; Kim Y; Lim Y; Han I; Oh ES
J Biol Chem; 2002 Aug; 277(33):29730-6. PubMed ID: 12055189
[TBL] [Abstract][Full Text] [Related]
3. Syndecan-2 functions as a docking receptor for pro-matrix metalloproteinase-7 in human colon cancer cells.
Ryu HY; Lee J; Yang S; Park H; Choi S; Jung KC; Lee ST; Seong JK; Han IO; Oh ES
J Biol Chem; 2009 Dec; 284(51):35692-701. PubMed ID: 19858218
[TBL] [Abstract][Full Text] [Related]
4. Decreased syndecan-2 expression correlates with trichostatin-A induced-morphological changes and reduced tumorigenic activity in colon carcinoma cells.
Kim Y; Park H; Lim Y; Han I; Kwon HJ; Woods A; Oh ES
Oncogene; 2003 Feb; 22(6):826-30. PubMed ID: 12584561
[TBL] [Abstract][Full Text] [Related]
5. Syndecan-1 expression in thyroid carcinoma: stromal expression followed by epithelial expression is significantly correlated with dedifferentiation.
Ito Y; Yoshida H; Nakano K; Takamura Y; Miya A; Kobayashi K; Yokozawa T; Matsuzuka F; Matsuura N; Kuma K; Miyauchi A
Histopathology; 2003 Aug; 43(2):157-64. PubMed ID: 12877731
[TBL] [Abstract][Full Text] [Related]
6. Syndecan-2 expression in colorectal cancer-derived HT-29 M6 epithelial cells induces a migratory phenotype.
Contreras HR; Fabre M; Granés F; Casaroli-Marano R; Rocamora N; Herreros AG; Reina M; Vilaró S
Biochem Biophys Res Commun; 2001 Aug; 286(4):742-51. PubMed ID: 11520060
[TBL] [Abstract][Full Text] [Related]
7. Syndecan-1 expression is up-regulated in pancreatic but not in other gastrointestinal cancers.
Conejo JR; Kleeff J; Koliopanos A; Matsuda K; Zhu ZW; Goecke H; Bicheng N; Zimmermann A; Korc M; Friess H; Büchler MW
Int J Cancer; 2000 Oct; 88(1):12-20. PubMed ID: 10962434
[TBL] [Abstract][Full Text] [Related]
8. Reduction of syndecan-1 expression in differentiated type early gastric cancer and background mucosa with gastric cellular phenotype.
Watari J; Saitoh Y; Fujiya M; Shibata N; Tanabe H; Inaba Y; Okamoto K; Maemoto A; Ohta T; Yasuda A; Ayabe T; Ashida T; Yokota K; Obara T; Kohgo Y
J Gastroenterol; 2004; 39(2):104-12. PubMed ID: 15069616
[TBL] [Abstract][Full Text] [Related]
9. Shed syndecan-2 enhances tumorigenic activities of colon cancer cells.
Choi S; Choi Y; Jun E; Kim IS; Kim SE; Jung SA; Oh ES
Oncotarget; 2015 Feb; 6(6):3874-86. PubMed ID: 25686828
[TBL] [Abstract][Full Text] [Related]
10. Focal adhesion kinase regulates syndecan-2-mediated tumorigenic activity of HT1080 fibrosarcoma cells.
Park H; Han I; Kwon HJ; Oh ES
Cancer Res; 2005 Nov; 65(21):9899-905. PubMed ID: 16267014
[TBL] [Abstract][Full Text] [Related]
11. The role of syndecan-1 in malignancies.
Inki P; Jalkanen M
Ann Med; 1996 Feb; 28(1):63-7. PubMed ID: 8932508
[TBL] [Abstract][Full Text] [Related]
12. The extracellular domain of syndecan-2 regulates the interaction of HCT116 human colon carcinoma cells with fibronectin.
Kwon MJ; Kim Y; Choi Y; Kim SH; Park S; Han I; Kang DH; Oh ES
Biochem Biophys Res Commun; 2013 Feb; 431(3):415-20. PubMed ID: 23333331
[TBL] [Abstract][Full Text] [Related]
13. Syndecan-2 regulates cell migration in colon cancer cells through Tiam1-mediated Rac activation.
Choi Y; Kim H; Chung H; Hwang JS; Shin JA; Han IO; Oh ES
Biochem Biophys Res Commun; 2010 Jan; 391(1):921-5. PubMed ID: 19962968
[TBL] [Abstract][Full Text] [Related]
14. Steroid-induced epithelial-fibroblastic conversion associated with syndecan suppression in S115 mouse mammary tumor cells.
Leppä S; Härkönen P; Jalkanen M
Cell Regul; 1991 Jan; 2(1):1-11. PubMed ID: 2007184
[TBL] [Abstract][Full Text] [Related]
15. Syndecan-2.
Essner JJ; Chen E; Ekker SC
Int J Biochem Cell Biol; 2006 Feb; 38(2):152-6. PubMed ID: 16198615
[TBL] [Abstract][Full Text] [Related]
16. Cell surface heparan sulfate proteoglycans control adhesion and invasion of breast carcinoma cells.
Lim HC; Multhaupt HA; Couchman JR
Mol Cancer; 2015 Jan; 14(1):15. PubMed ID: 25623282
[TBL] [Abstract][Full Text] [Related]
17. High syndecan-1 expression in breast carcinoma is related to an aggressive phenotype and to poorer prognosis.
Barbareschi M; Maisonneuve P; Aldovini D; Cangi MG; Pecciarini L; Angelo Mauri F; Veronese S; Caffo O; Lucenti A; Palma PD; Galligioni E; Doglioni C
Cancer; 2003 Aug; 98(3):474-83. PubMed ID: 12879463
[TBL] [Abstract][Full Text] [Related]
18. Syndecan-2 overexpression regulates adhesion and migration through cooperation with integrin alpha2.
Choi S; Kim Y; Park H; Han IO; Chung E; Lee SY; Kim YB; Lee JW; Oh ES; Yi JY
Biochem Biophys Res Commun; 2009 Jun; 384(2):231-5. PubMed ID: 19394307
[TBL] [Abstract][Full Text] [Related]
19. Soluble and matrix-associated heparan sulfate proteoglycans increase expression of erb-B2 and erb-B3 in colon cancer cell lines.
Zvibel I; Brill S; Halpern Z; Moskovitz S; Yayon A; Papa M
Int J Cancer; 2001 Feb; 91(3):316-21. PubMed ID: 11169953
[TBL] [Abstract][Full Text] [Related]
20. The role of syndecan-2 in regulation of actin-cytoskeletal organization of Lewis lung carcinoma-derived metastatic clones.
Munesue S; Kusano Y; Oguri K; Itano N; Yoshitomi Y; Nakanishi H; Yamashina I; Okayama M
Biochem J; 2002 Apr; 363(Pt 2):201-9. PubMed ID: 11931647
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
